<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Neurol</journal-id>
      <journal-title-group>
        <journal-title>BMC Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2377</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27619214</article-id>
      <article-id pub-id-type="pmc">5020510</article-id>
      <article-id pub-id-type="publisher-id">694</article-id>
      <article-id pub-id-type="doi">10.1186/s12883-016-0694-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Involvement of the optic nerve in mutated <italic>CSF1R</italic>-induced hereditary diffuse leukoencephalopathy with axonal spheroids</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Shu</surname>
            <given-names>Yaqing</given-names>
          </name>
          <address>
            <email>shuyaqing@126.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Long</surname>
            <given-names>Ling</given-names>
          </name>
          <address>
            <email>linglinglively@126.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liao</surname>
            <given-names>Siyuan</given-names>
          </name>
          <address>
            <email>386997730@qq.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Jiezheng</given-names>
          </name>
          <address>
            <email>hs_young@126.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Jianfang</given-names>
          </name>
          <address>
            <email>lijianfang926@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Qiu</surname>
            <given-names>Wei</given-names>
          </name>
          <address>
            <email>qw9406@Gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Yu</given-names>
          </name>
          <address>
            <email>yangyu201201@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bao</surname>
            <given-names>Jian</given-names>
          </name>
          <address>
            <email>baojian2013@sina.cn</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>Aiming</given-names>
          </name>
          <address>
            <email>wuaim@126.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Hu</surname>
            <given-names>Xueqiang</given-names>
          </name>
          <address>
            <email>huxueqiangqm@aliyun.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lu</surname>
            <given-names>Zhengqi</given-names>
          </name>
          <address>
            <email>lzq1828@aliyun.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Neurology, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou, 510630 China </aff>
        <aff id="Aff2"><label>2</label>Department of Ophthalmology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630 China </aff>
        <aff id="Aff3"><label>3</label>Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630 China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>13</day>
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>16</volume>
      <issue>1</issue>
      <elocation-id>171</elocation-id>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>4</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>1</day>
          <month>9</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s). 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) is a rare autosomal dominant disorder characterized by cerebral white matter degeneration and caused by mutations in the <italic>colony-stimulating factor 1 receptor</italic> (<italic>CSF1R</italic>) gene. Involvement of the optic nerves in hereditary diffuse leukoencephalopathy is rare.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We report the case of a 30-year-old Chinese woman with HDLS, who carried a heterozygous c.2345&#xA0;G&#x2009;&gt;&#x2009;A (p.782Arg&#x2009;&gt;&#x2009;His) mutation in exon 18 of <italic>CSF1R</italic>. She developed a gradual decline in motor ability, as well as cognitive and visual function, over the course of 4&#xA0;months. Brain T2 fluid-attenuated inversion recovery-weighted magnetic resonance imaging revealed high signal lesions in the bilateral frontoparietal and periventricular deep white matter. Optical coherence tomography showed that the right peripapillary retinal nerve fiber layer was atrophic in the temporal quadrant while the left peripapillary retinal nerve fiber layer was thin in the temporal superior quadrant.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>A diagnosis of HDLS should be considered in patients with white matter lesions and optic nerves injury upon magnetic resonance imaging that mimics progressive multiple sclerosis.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Leukoencephalopathy</kwd>
        <kwd>Colony-stimulating factor 1 receptor</kwd>
        <kwd>Peripapillary retinal nerve fiber layer</kwd>
        <kwd>Hereditary diffuse leukoencephalopathy with axonal spheroids</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
              <institution>National Natural Science Foundation of China</institution>
            </institution-wrap>
          </funding-source>
          <award-id>no. 81301088</award-id>
          <principal-award-recipient>
            <name>
              <surname>Long</surname>
              <given-names>Ling</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) is a rare autosomal dominant disorder characterized by cerebral white matter degeneration with axonal spheroids with variable clinical presentations, including personality and behavioral changes, dementia, depression, parkinsonism, and seizures. HDLS was first identified in a Western Swedish family reported in 1984 [<xref ref-type="bibr" rid="CR1">1</xref>] and is caused by mutations in the <italic>colony-stimulating factor 1 receptor</italic> (<italic>CSF1R</italic>) gene [<xref ref-type="bibr" rid="CR2">2</xref>]. HDLS appears as white matter lesions in a frontal predominant distribution upon brain magnetic resonance imaging (MRI), spreading out from the periventricular and deep white matter into the subcortical areas with enlarged ventricles and often signal changes in the corpus callosum [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. However, involvement of the optic nerves has not been previously reported in HDLS. We describe a HDLS patient who also had optic nerve lesions.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 30-year-old, non-smoking woman was referred to our hospital in August 2015, with a 4-month history of progressive lower limb weakness, gait disturbance, and visual disorder. Her mother experienced right lower limb weakness at 40&#xA0;years of age, followed by progressive cognitive and motor deterioration and death at 60&#xA0;years of age. The case family pedigree is shown in Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><p>Family pedigree. The arrow indicates the proband (present patient). Her mother developed a motor disorder at 40&#xA0;years of age and died at 60&#xA0;years of age. Her grandparents, father, brothers, sisters, and daughters were not affected</p></caption><graphic xlink:href="12883_2016_694_Fig1_HTML" id="MO1"/></fig></p>
      <p>Prior to admission to our hospital, the patient exhibited neuropsychiatric symptoms, such as paraphasia and hallucination. She was diagnosed with multiple sclerosis (MS) and received immunotherapy with intravenous methylprednisolone at another hospital. However, her motor function progressively declined and she experienced frequent falls. When she was admitted to our hospital, her mini-mental state examination (MMSE) score was 25/30, with a Montreal cognitive assessment scale (MoCA) score of 17/30. The activities of daily living (ADL) score was 50/100 and the Morse fall risk factors assessment scale score was 45. Bilateral visual acuity was 0.8, muscle tone in her lower limbs increased, and muscle strength of the lower limbs was grade 4. She developed a spastic gait and an unsteady broad-based gait. Romberg&#x2019;s sign, Babinski&#x2019;s sign, and Chaddock&#x2019;s sign were all positive.</p>
      <p>Most laboratory tests were normal/negative, including the serum erythrocyte sedimentation rate, C-reactive protein, vitamins (B1\B2\B6\B9\B12), glycosylated hemoglobin, thyroid function, serum copper, ceruloplasmin, anti-nuclear antibody, paraneoplastic antibodies, and antibodies specific for the following: myelin oligodendrocyte glycoprotein, myelin-associated glycoprotein, myelin basic protein, and aquaporin-4. Serum treponema pallidum antibody, rapid plasma reagin, tolulized red unheated serum test, and human immunodeficiency virus antibody were all negative. Cerebrospinal fluid tests were normal, including negative oligoclonal IgG bands.</p>
      <p>Brain T2 fluid-attenuated inversion recovery (FLAIR) MRI showed multiple, asymmetrical, hyperintense lesions, which appeared in periventricular areas and the white matter regions of the frontal and parietal lobes. Diffusion-weighted imaging (DWI) showed small dots of diffusion restriction within the white matter lesions. Magnetic resonance spectroscopy (MRS) showed increased levels of choline (Cho), although N-acetylaspartate (NAA) was decreased. Diffusion tensor imaging (DTI) revealed corpus callosum fiber loss, although fibers of the bilateral frontal, parietal, occipital, and temporal lobe and brainstem fibers were spared (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Brain MRI, DWI, DTI, and MRS images. T2/Flair showed multifocal periventricular white matter lesions (<bold>a b</bold> and <bold>c</bold>), without enhancement (<bold>d</bold>). DWI shows high-signal intensities in periventricular white matters and corpus callosum (<bold>e f</bold>). DTI shows decreased numbers of corpus callosum fibers, while subcortical arcuate fibers are spared (<bold>g</bold>). MRS shows increased Cho levels, while NAA levels are decreased in the white matter lesions (<bold>h i</bold>)</p></caption><graphic xlink:href="12883_2016_694_Fig2_HTML" id="MO2"/></fig></p>
      <p>Optic nerve MRI demonstrated bilateral optic nerves lesions (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). Optical coherence tomography (OCT) showed that the right peripapillary retinal nerve fiber layer (pRNFL) was atrophic (pRNFL thickness 43&#x2013;50&#xA0;&#x3BC;m) in the temporal quadrant, and the left pRNFL was thin (65&#xA0;&#x3BC;m) in the temporal superior quadrant (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>). Average RNFL thickness in healthy controls has been shown to be 93&#x2013;108&#xA0;&#x3BC;m [<xref ref-type="bibr" rid="CR5">5</xref>]. Visual-evoked potential (VEP) showed reduced amplitudes of bilateral P100, although latencies of bilateral P100 were normal (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>). Bilateral intraocular pressures (both 15&#xA0;mmHg) were normal. The visual fields of both eyes were partially missing in the different quadrants (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>Optic nerves on MRI, showing that bilateral optic nerves are injured (red arrows)</p></caption><graphic xlink:href="12883_2016_694_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>OCT shows that the right peripapillary retinal nerve fiber layer (pRNFL) is atrophic in the temporal quadrant, and the left pRNFL is thinning in the temporal superior quadrants. Green represents pRNFL thickness, which is within normal limits; yellow represents pRNFL thickness, which is below borderline; red represents pRNFL thickness, which is below normal limits</p></caption><graphic xlink:href="12883_2016_694_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><p>VEP shows reduced bilateral P100 amplitudes, although P100 latencies are normal in both eyes</p></caption><graphic xlink:href="12883_2016_694_Fig5_HTML" id="MO5"/></fig><fig id="Fig6"><label>Fig. 6</label><caption><p>Visual fields in the right eye are partially missing in the upper right, lower right, and lower left quadrants, especially in the lower right quadrant. Visual fields in the left eye are partially missing in the four quadrants, especially in the upper left and lower right quadrants</p></caption><graphic xlink:href="12883_2016_694_Fig6_HTML" id="MO6"/></fig></p>
      <p>Methylprednisolone therapy with two treatment courses (1000&#xA0;mg/day for 5&#xA0;days and 1000&#xA0;mg/day for 3&#xA0;days) resulted in no improvement. Genetic studies for leukodystrophy-related genes showed that a c.2345&#xA0;G&#x2009;&gt;&#x2009;A (p.782Arg&#x2009;&gt;&#x2009;His) mutation in exon 18 of <italic>CSF1R</italic> was present (Fig.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref>), which has been proven to be the pathogenic gene for HDLS. However, a brain biopsy was refused by the patient and her family. Seven months after discharge from our hospital, she showed progressive decline and reached a vegetative state and died on May 18, 2016.<fig id="Fig7"><label>Fig. 7</label><caption><p>Gene analysis of <italic>CSF1R</italic>. The sequencing result from exon 18 of <italic>CSF1R</italic> (NM_005211.3) indicates a heterozygous c.2345&#xA0;G&#x2009;&gt;&#x2009;A (p.782Arg&#x2009;&gt;&#x2009;His) substitution in the patient</p></caption><graphic xlink:href="12883_2016_694_Fig7_HTML" id="MO7"/></fig></p>
      <p>The present case describes a patient with a genetically confirmed HDLS and a heterozygous c.2345&#xA0;G&#x2009;&gt;&#x2009;A (p.782Arg&#x2009;&gt;&#x2009;His) mutation in exon 18 of the <italic>CSFR1</italic>, which was previously described by Kinoshita et al. [<xref ref-type="bibr" rid="CR6">6</xref>]. HDLS has an autosomal dominant pattern of inheritance, and it may be sporadic. In our case, we presume that the patient&#x2019;s mother was affected, because of early-onset motor impairment over the course of her illness. Unfortunately, however, there were no clinical data or brain biopsy samples from her mother.</p>
      <p>In the present case, the patient experienced visual impairment and optic nerve impairment, which made it difficult to differentiate the disease from MS. Optic nerve injury lacking gadolinium enhancement was revealed by brain MRI, and the right temporal pRNFL was atrophic and left temporal superior pRNFL was thin upon OCT. To the best of our knowledge, involvement of the optic nerves has never been reported in HDLS, and the mechanism of optic nerve impairment in HDLS remains unknown. HDLS is pathologically characterized by non-inflammatory myelin loss, reactive astrocytosis, and axonal spheroids. Axonal spheroids of peripheral neuropathy have been found in HDLS, suggesting more widespread nervous system involvement [<xref ref-type="bibr" rid="CR7">7</xref>]. We hypothesized that non-inflammatory myelin loss and axonal spheroids might also be involved in the optic nerves in our HDLS case. Additionally, OCT, which has emerged as a novel tool to depict neuro-axonal damage in MS by measuring non-myelinated central nervous system axons in the retina [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], was also used to analyze RNFL thickness that is the better parameter for monitoring longitudinal axonal damage [<xref ref-type="bibr" rid="CR9">9</xref>]. RNFL thickness has also been linked to metabolic signs of neurodegeneration in the visual cortex [<xref ref-type="bibr" rid="CR10">10</xref>]. Several reports of MS patients have correlated RNFL atrophy with brain atrophy in patients with and without optic neuritis [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. In our case, brain MRI showed multiple lesions in the white and gray matter, and DTI revealed lost or spared white and gray matter fibers. These results suggested that RNFL atrophy in OCT might be associated with brain abnormalities in HDLS. We hypothesized that the features revealed by OCT and neuroimaging might be related to axonal and myelin destruction in white matter lesions in HDLS.</p>
      <p>The clinical features in the present case predominantly included progressive gait disturbance and cognitive and motor impairment that mimicked progressive MS, although the patient also exhibited atypical parkinsonian features, including bradykinesia and rigidity, which have been previously reported [<xref ref-type="bibr" rid="CR12">12</xref>&#x2013;<xref ref-type="bibr" rid="CR14">14</xref>]. Although the mechanisms of atypical Parkinsonism remain unclear, it has been suggested that the disconnected fiber tracts in white matter lesions are structurally or functionally critical for performing movements [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Subcortical and periventricular white matter lesions might interfere with ascending thalamocortical and descending corticospinal fibers, and a large number of white matter lesions have been observed in HDLS.</p>
    </sec>
    <sec id="Sec3">
      <title>Conclusions</title>
      <p>Results from the present case study suggest that optic nerves can be involved in HDLS. RNFL atrophy observed by OCT might be associated with brain abnormalities in HDLS. Molecular analysis of the <italic>CSF1R</italic> gene should be performed when HDLS clinically and radiologically mimics progressive multiple sclerosis.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ADL</term>
          <def>
            <p>Activities of daily living</p>
          </def>
        </def-item>
        <def-item>
          <term>Choline</term>
          <def>
            <p>Cho</p>
          </def>
        </def-item>
        <def-item>
          <term>
            <italic>CSF1R</italic>
          </term>
          <def>
            <p>Colony stimulating factor 1 receptor</p>
          </def>
        </def-item>
        <def-item>
          <term>DTI</term>
          <def>
            <p>Diffusion tensor imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>DWI</term>
          <def>
            <p>Diffusion weighted imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>HDLS</term>
          <def>
            <p>Hereditary diffuse leukoencephalopathy with axonal spheroids</p>
          </def>
        </def-item>
        <def-item>
          <term>MMSE</term>
          <def>
            <p>Mini-mental state examination</p>
          </def>
        </def-item>
        <def-item>
          <term>MoCA</term>
          <def>
            <p>Montreal cognitive assessment scale</p>
          </def>
        </def-item>
        <def-item>
          <term>MRI</term>
          <def>
            <p>Magnetic resonance imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>MRS</term>
          <def>
            <p>Magnetic resonance spectroscopy</p>
          </def>
        </def-item>
        <def-item>
          <term>MS</term>
          <def>
            <p>Multiple sclerosis</p>
          </def>
        </def-item>
        <def-item>
          <term>NAA</term>
          <def>
            <p>N-acetylaspartate</p>
          </def>
        </def-item>
        <def-item>
          <term>OCT</term>
          <def>
            <p>Optical coherence tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>pRNFL</term>
          <def>
            <p>Peripapillary retinal nerve fiber layer</p>
          </def>
        </def-item>
        <def-item>
          <term>T2 FLAIR</term>
          <def>
            <p>T2 fluid-attenuated inversion recovery</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <title>Acknowledgements</title>
      <p>We wish to thank our patient and her family.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>The study was supported by grants from the National Natural Science Foundation of China (no. 81301088).</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and materials</title>
        <p>The datasets supporting the conclusions of this article are available in the zenodo repository. Figures are available on <ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/57426">https://zenodo.org/record/57426</ext-link>.</p>
      </sec>
      <sec id="FPar3">
        <title>Authors&#x2019; contributions</title>
        <p>ZQ-L and XQ-H interviewed, diagnosed and treated the patient. YQ-S and LL interpreted the data and drafted the manuscript for content. JZ- Y carried our eyes test in this patient. JF-L did the MRI for the patients. SY-L and WQ interviewed the patient and did the Gene analysis for the patient. YY, JB and AM-W contributed to the follow-up of the patients and literature reviewing. All authors read and approved the final manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar5">
        <title>Consent for publication</title>
        <p>Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
      </sec>
      <sec id="FPar6">
        <title>Ethics approval and consent to participate</title>
        <p>This research was approved by the ethics committee of the Third Affiliated Hospital of Sun Yat-sen University. The patient consented to participate in this study.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Axelsson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Roytta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sourander</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Akesson</surname>
              <given-names>HO</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Hereditary diffuse leucoencephalopathy with spheroids</article-title>
          <source>Acta Psychiatr Scand Suppl</source>
          <year>1984</year>
          <volume>314</volume>
          <fpage>1</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">6595937</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="other">Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet. 2012;44(2):200&#x2013;5.</mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kondo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fukushima</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Early involvement of the corpus callosum in a patient with hereditary diffuse leukoencephalopathy with spheroids carrying the de novo K793T mutation of CSF1R</article-title>
          <source>Intern Med</source>
          <year>2013</year>
          <volume>52</volume>
          <issue>4</issue>
          <fpage>503</fpage>
          <lpage>506</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.52.8879</pub-id>
          <pub-id pub-id-type="pmid">23411710</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="other">Sundal C, Van Gerpen JA, Nicholson AM, Wider C, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, et al. MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology. 2012;79(6):566&#x2013;74.</mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="other">Bennett JL, de Seze J, Lana-Peixoto M, Palace J, Waldman A, Schippling S, Tenembaum S, Banwell B, Greenberg B, Levy M, et al. Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography. Mult Scler. 2015;21(6):678&#x2013;88.</mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kinoshita</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Oyanagi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Hereditary diffuse leukoencephalopathy with axonal spheroids caused by R782H mutation in CSF1R: case report</article-title>
          <source>J Neurol Sci</source>
          <year>2012</year>
          <volume>318</volume>
          <issue>1&#x2013;2</issue>
          <fpage>115</fpage>
          <lpage>118</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jns.2012.03.012</pub-id>
          <pub-id pub-id-type="pmid">22503135</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="other">Di Donato I, Stabile C, Bianchi S, Taglia I, Mignarri A, Salvatore S, Giorgio E, Brusco A, Simone I, Dotti MT, et al. A Novel CSF1R Mutation in a Patient with Clinical and Neuroradiological Features of Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids. J Alzheimers Dis. 2015;47(2):319&#x2013;22.</mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="other">Zimmermann H, Freing A, Kaufhold F, Gaede G, Bohn E, Bock M, Oberwahrenbrock T, Young KL, Dorr J, Wuerfel JT, et al. Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Mult Scler. 2013;19(4):443&#x2013;50.</mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <mixed-citation publication-type="other">Dorr J, Wernecke KD, Bock M, Gaede G, Wuerfel JT, Pfueller CF, Bellmann-Strobl J, Freing A, Brandt AU, Friedemann P. Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One. 2011;6(4):e18132.</mixed-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <mixed-citation publication-type="other">Pfueller CF, Brandt AU, Schubert F, Bock M, Walaszek B, Waiczies H, Schwenteck T, Dorr J, Bellmann-Strobl J, Mohr C. et al. Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis. PLoS One. 2011;6(4):e18019.</mixed-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <mixed-citation publication-type="other">Young KL, Brandt AU, Petzold A, Reitz LY, Lintze F, Paul F, Martin R, Schippling S. Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis. Eur J Neurol. 2013;20(5):803&#x2013;11.</mixed-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="other">Saitoh BY, Yamasaki R, Hayashi S, Yoshimura S, Tateishi T, Ohyagi Y, Murai H, Iwaki T, Yoshida K, Kira J. A case of hereditary diffuse leukoencephalopathy with axonal spheroids caused by a de novo mutation in CSF1R masquerading as primary progressive multiple sclerosis. Mult Scler. 2013;19(10):1367&#x2013;70.</mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keegan</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Giannini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Parisi</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Lucchinetti</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Boeve</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Josephs</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS</article-title>
          <source>Neurology</source>
          <year>2008</year>
          <volume>70</volume>
          <issue>13 Pt 2</issue>
          <fpage>1128</fpage>
          <lpage>1133</lpage>
          <pub-id pub-id-type="doi">10.1212/01.wnl.0000304045.99153.8f</pub-id>
          <pub-id pub-id-type="pmid">18287567</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <mixed-citation publication-type="other">Sundal C, Fujioka S, Van Gerpen JA, Wider C, Nicholson AM, Baker M, Shuster EA, Aasly J, Spina S, Ghetti B, et al. Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism Relat Disord. 2013;19(10):869&#x2013;77.</mixed-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bohnen</surname>
              <given-names>NI</given-names>
            </name>
            <name>
              <surname>Albin</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>White matter lesions in Parkinson disease</article-title>
          <source>Nat Rev Neurol</source>
          <year>2011</year>
          <volume>7</volume>
          <issue>4</issue>
          <fpage>229</fpage>
          <lpage>236</lpage>
          <pub-id pub-id-type="doi">10.1038/nrneurol.2011.21</pub-id>
          <pub-id pub-id-type="pmid">21343896</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <mixed-citation publication-type="other">Bonilha L, de Vries PM, Hurd MW, Rorden C, Morgan PS, Besenski N, Bergmann KJ, Hinson VK. Disrupted thalamic prefrontal pathways in patients with idiopathic dystonia. Parkinsonism Relat Disord. 2009;15(1):64&#x2013;7.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
